Growth is driven by rising demand for cost-effective tire solutions across logistics, mining, construction, and public transport fleets.

This comes as the population ages and chronic conditions rise. The TAC-302 therapy is anticipated to capture the highest market for the underactive bladder syndrome (UAB) in China and seven other ...

I assigned a Hold rating to ImmunityBio, Inc. (IBRX) stock back in September last year in a note for Seeking Alpha, and prior to that, a Hold rating in April 2025, and a Buy rating in December 2024.

There is a reason why the United States and Canada consider China a “non-market economy.” Beijing, rather than market forces, determines production and prices. Since China joined the World Trade ...